Clinical significance of the determination of angiogenic factors.
Toi
M
M
Department of Surgery, Tokyo Metropolitan Komagome Hospital, Japan.
Taniguchi
T
T
Yamamoto
Y
Y
Kurisaki
T
T
Suzuki
H
H
Tominaga
T
T
D016228:Endothelial Growth Factors / Q000378:metabolism / Q000502:physiology; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism / Q000502:physiology; D017228:Hepatocyte Growth Factor / Q000378:metabolism / Q000502:physiology; D006801:Humans; D008222:Lymphokines / Q000378:metabolism / Q000502:physiology; D009369:Neoplasms / Q000098:blood supply* / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000503:physiopathology*; D011379:Prognosis; D013939:Thymidine Phosphorylase / Q000378:metabolism / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; D017228:Hepatocyte Growth Factor; D013939:Thymidine Phosphorylase